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Abstract
Background: With increasing knowledge about the potential mechanisms underlying cellular functions, it is
becoming feasible to predict the response of biological systems to genetic and environmental perturbations. Due
to the lack of homogeneity in living tissues it is difficult to estimate the physiological effect of chemicals, including
potential toxicity. Here we investigate a biologically motivated model for estimating tissue level responses by
aggregating the behavior of a cell population. We assume that the molecular state of individual cells is
independently governed by discrete non-deterministic signaling mechanisms. This results in noisy but highly
reproducible aggregate level responses that are consistent with experimental data.
Results: We developed an asynchronous threshold Boolean network simulation algorithm to model signal
transduction in a single cell, and then used an ensemble of these models to estimate the aggregate response
across a cell population. Using published data, we derived a putative crosstalk network involving growth factors
and cytokines - i.e., Epidermal Growth Factor, Insulin, Insulin like Growth Factor Type 1, and Tumor Necrosis Factor
a - to describe early signaling events in cell proliferation signal transduction. Reproducibility of the modeling
technique across ensembles of Boolean networks representing cell populations is investigated. Furthermore, we
compare our simulation results to experimental observations of hepatocytes reported in the literature.
Conclusion: A systematic analysis of the results following differential stimulation of this model by growth factors
and cytokines suggests that: (a) using Boolean network ensembles with asynchronous updating provides
biologically plausible noisy individual cellular responses with reproducible mean behavior for large cell populations,
and (b) with sufficient data our model can estimate the response to different concentrations of extracellular
ligands. Our results suggest that this approach is both quantitative, allowing statistical verification and calibration,
and extensible, allowing modification and revision as guided by experimental evidence. The simulation
methodology is part of the US EPA Virtual Liver, which is investigating the effects of everyday contaminants on
living tissues. Future models will incorporate additional crosstalk surrounding proliferation as well as the putative
effects of xenobiotics on these signaling cascades within hepatocytes.
Background
Motivation
Thousands of chemicals are used in commerce and eval-
uating their public health risk remains a challenging
problem [1,2]. Much of our knowledge about mechan-
isms of toxicity is based on evidence from in vivo animal
studies and in vitro experiments, where we can begin to
unravel some of the molecular signaling and transcrip-
tional changes induced via chemical perturbation; how-
ever, there are three main issues in translating these
findings to humans. First, it is often impractical to
design experiments with sufficient power to detect the
subtle effects of very low environmentally relevant expo-
sures [3]. Hence most observations about chemical
effects are at relatively high concentrations that cannot
be easily used to quantify the risk of long-term and low-
dose exposure to complex mixtures of chemicals [4].
Second, since the molecular response to chemicals is
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not always conserved between species [5], the effects
observed in rodents cannot be directly extrapolated from
rodents to humans without additional mechanistic
insight [6]. Third, toxicity is a tissue level phenomenon
arising from the behaviors of heterogeneous cell popula-
tions. Understanding the complex signaling processes
between these different cell types is crucial in determin-
ing toxicity potential. We are building a cell-based tissue
model to estimate the quantitative population-level
effects of chemical exposures [7,8]. Here we describe an
asynchronous threshold Boolean network (BN) approach
to model signal transduction in individual cells and to
estimate tissue level responses using an ensemble of BNs.
Boolean Networks
A BN describes a signaling network as a digital circuit in
which logical elements (proteins or genes) are either
‘ON’ or ‘OFF’. The temporal evolution of the signaling
network is calculated using a set of Boolean functions
(AND, OR, NOT) to model regulatory interactions.
Since they offer a biologically relevant and computation-
ally efficient formalism for analyzing the relationship
between molecular network topology and function, BNs
have been used extensively to simulate the behavior of
cells based on their network activity. Genetic regulatory
networks have been particularly amenable to this form-
alism due to the binary nature of gene activation [9].
The availability of large-scale transcriptional profiles
spurred more recent applications of deterministic [10]
and probabilistic [11] BNs for reconstructing and simu-
lating genetic regulatory networks. Additionally, BNs
have been used for modeling the cell cycle [12-15]; cell
proliferation [16-18]; apoptosis [19]; and cancer [20].
BNs can be used to represent the binary activity of
molecular species across cell populations (in vitro and
in vivo). One of the limitations of BNs is that they can-
not readily estimate continuous functional responses, i.
e., quantitative dose-response, which are fundamentally
important in pharmacology and toxicology.
Cancer Pathways
Liver cancer is a frequent outcome in testing the long-
term effects of chemicals in rodents [21] and often con-
sidered in regulatory decisions [22]. Since the mechan-
isms of carcinogenesis are poorly understood, it is
difficult to translate chemical effects from rodents to
humans. Cancer is believed to arise due to a breakdown
of the homeostatic processes that maintain balance
between cell death and division [23]. Some chemicals
(called mutagens) can alter cell phenotypes by damaging
DNA resulting in harmful mutations that can spur the
activation of oncogenes. Nongenotoxic carcinogens, on
the other hand, can act via insidious mechanisms that
suppress apoptosis or to stimulate cell proliferation.
It has been suggested that nongenotoxic carcinogens
may increase hepatocyte proliferation by perturbing the
crosstalk network regulated by growth factors and cyto-
kines [24]. Crosstalk refers to the sequence of protein
regulation activated by any one growth factor or cyto-
kine ligand overlapping with the sequences of other
ligands, which allows for complex behavior. The pre-
sence of crosstalk allows a cell to behave as a multi-
plexer, integrating multiple signals to select from many
possible outcomes, such as cell cycle initiation and
progression.
A number of computational models have been pro-
posed for simulating cell proliferation [12-18,25], how-
ever, BNs have not been extensively used in modeling
chemical induced toxicity or in hepatic biology. In order
for a chemical to produce a chronic or acute tissue level
effect, there must be some level of perturbed protein
activity in the signal transduction of one or more cells.
We are evaluating BNs for modeling early molecular sig-
naling events in hepatocytes that lead to proliferative
changes, which are key events in carcinogenesis. Hence,
our initial objective is to model some of the normal
cues, i.e. homeostatic processes, that can stimulate
healthy, quiescent hepatocytes (G0) into entering the
cell cycle (G1).
Technological advancements such as flow cytometry
and high content screening have made it possible to
measure protein levels with single cell resolution.
Experimental observations suggest that protein levels
within cells may exhibit a switch-like ‘all’ or ‘nothing’
(’ON’ or ‘OFF’) response - for example, p53 response to
DNA damage [26,27], TNFa stimulation [28,29], MAPK
signaling events [30], and drug treatment [31]. These
types of observations serve as a foundation for the
hypothesis that a Boolean representation is sufficient for
describing the molecular multiplicities of individual cells
in a simulation framework. Next, we assume that the
aggregate activity of molecules across a population of
hundreds, thousands or millions of cells can be used to
estimate tissue level responses.
Key Contributions
Our work is based on two extensions of asynchronous
BNs, which employ a non-deterministic updating
scheme. First, we use threshold functions to calculate
the activation of each protein in our model. This techni-
que has been applied to other systems [32,33], and it
provides a simple representation and adjustable para-
meter for investigating the interactions between signal-
ing molecules. Second, we model an ensemble of BNs to
simulate the quantitative responses of thousands of
cells. As such, we can estimate dose dependent
responses of cell populations. We defined the topology
of the BN semi-automatically using structured
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information about canonical signaling network from a
public pathway repository. Here we describe our initial
results on the reproducibility of asynchronous threshold
Boolean network ensembles and their potential utility
for estimating quantitative time- and concentration-
dependent biological responses.
Results
Cell Signaling Network Construction
We used the Science Signaling database (or STKE)
[34-37] to construct the protein signaling network. The
canonical pathways in the network include: Epidermal
Growth Factor (EGF) signaling, Insulin (INS) signaling,
Insulin like Growth Factor type 1 (IGF-1) signaling, and
Tumor Necrosis Factor alpha (TNFa) signaling. The
number of proteins and molecular interactions in each
of these pathways are summarized in Table 1. We per-
formed several steps to systematically build a crosstalk
network from these canonical pathways. First, we com-
bined all of the proteins and interactions from the four
pathways into one integrated molecular interaction net-
work. After filtering for uniqueness among proteins and
interactions, we produced a non-redundant crosstalk
network with 102 proteins and 150 interactions. Second,
we excluded the proteins and interactions that did not
lead to c-Jun and c-Fos activity, which are important
components in the formation of the activator protein 1
(AP-1) transcription factor complex.
In our initial model, we focused on early signaling
events in cell proliferation and did not consider gene
expression changes which lead to mitosis. Hence, we
assumed that AP-1 formation, encoded as a c-Jun/c-Fos
dimer, is an early marker of cell cycle progression. This
allowed us to further simplify the network by removing
all proteins and interactions that are not on a pathway
from one of the four receptors to either c-Jun or c-Fos.
Furthermore, we manually removed an additional six
proteins with in degree less than 2. We did, however,
leave some proteins with in degree less than two: the
extracellular ligands and their receptors, as well as Rat
Sarcoma (RAS), ribosomal s6 kinase (RSK), v-erb-b2 ery-
throblastic leukemia viral oncogene homolog 2 (ErbB2)
and homolog 3 (ErbB3), Rho GTPase (RHO), p55 gamma
(p55g), Vav proto-oncogene (VAV), c-Jun, mitogen- and
stress-activated protein kinase 2 (MSK2), mitogen acti-
vated protein kinase kinase (MAPKK), phosphoinositide-
dependent kinase 1 (PDK1), and 1,2-Diacylglycerol
(DAG). These molecules are implicated in the EGF sig-
naling pathway, which was simulated and compared to in
vitro data, except p55g which is involved INS pathway.
Finally, we included in the model a molecular species
representing AP-1 transcription factor complex forma-
tion, by adding two additional interactions involving the
c-Jun and c-Fos dimerization. The final biochemical
interaction network contained 46 proteins and 77 inter-
actions. The protein signaling network in Figure 1 was
drawn with Cytoscape [38], an open source tool conveni-
ent for visualizing large scale networks.
Simulating individual cellular responses
We used the biochemical interaction network in Figure
1 to describe the response of an individual hepatocyte
to the growth factors (EGF, IGF-1 and INS) and the
inflammatory cytokine (TNFa). In order to simulate the
dynamics of signal transduction, we translated the bio-
chemical interaction network into a threshold BN. As in
a traditional BN approach, we assumed that: (a) proteins
in the network are described by one of two states, active
(ON) or inactive (OFF) and, (b) interactions result in
either the activation or inhibition of output proteins by
input proteins. Our approach deviates from traditional
BNs in three important ways. First, we replace the logi-
cal operators with an integer summation function that
incorporates an activation threshold. This allows us to
adjust the activating potential of each protein in the net-
work. Second, we employ a nondeterministic, asynchro-
nous updating scheme (see Methods), which can
simulate biological ‘noise’ observed in protein signaling
cascades. Third, we provide a method for using Hill
functions for calibrating the probability of activation for
proteins in the network, which can be calibrated with
concentration-response data.
In our methodology, the signaling network in a single
cell is represented as one asynchronous threshold BN.
Figure 2(A) illustrates the model of an individual cell as
a BN and its discrete dynamic response following treat-
ment with INS. The BN is constructed from the model
shown in Figure 1 (see Methods). The temporal evolu-
tion of protein activity in one BN is visualized as a heat-
map in Figure 2(A) (right panel). The abscissa of the
heatmap shows the simulation time steps (denoted as τ).
At τ = 0 the cell was ‘treated’ with INS by switching the
Table 1 Pathway Information for Building Crosstalk
Model
Pathway Proteins Interactions
Epidermal Growth Factor (EGF) 49 66
Insulin-like Growth Factor Type 1 (IGF-1) 8 7
Tumor Necrosis Factor alpha (TNFa) 24 37
Insulin (INS) 50 65
Merge Four Pathways 102 150
Subgraph: all paths from receptors to c-Jun
or c-Fos
55 89
Final network: remove with in degree = 0 46 77
We combined four pathways from the Science Signaling Database (STKE). The
first four rows of the table show the numbers of proteins and interactions in
each pathway. The last three rows show the numbers of proteins and
interactions as we merge and simplify the network.
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ligand from OFF to ON. Each column in the heatmap
shows the dynamic changes in the state of proteins
(given in the ordinate) at time steps following INS treat-
ment. The simulation continues until (τ = 369) when it
reaches a steady state, which involves the activation of
the AP-1 transcription factor complex. The discrete pro-
file of each protein shows the asynchronous dynamics of
signal transduction through the insulin receptor (IR) in
our crosstalk model (shown in Figure 1). In other
words, Figure 2a depicts a putative sequence of signaling
events that could occur in a single hepatocyte after insu-
lin stimulation. This result is qualitatively concordant
with in vitro observations on AP-1 formation following
insulin treatment [39]. Since the output of a single BN
is binary, however, it is difficult to evaluate the activa-
tion of AP-1 to different concentrations of INS or other
ligands for a single cell.
Simulating cell population responses
In order to estimate the quantitative response to treat-
ments, we assume that cell populations can be modeled
as an ensemble of asynchronous BNs. This allows us to
estimate the dynamic response across a simulated biolo-
gical sample as the aggregate activity of each protein
across thousands of BNs (see Methods). Hence, an
ensemble of BNs can be considered a simulated ‘repli-
cate’ as illustrated in Figure 2(B). We investigated the
response of an ensemble of 1000 asynchronous BNs to
treatment with INS (including the BN depicted in Figure
2(A) until all BNs reached a steady state. The resulting
aggregate activity profiles of IRS, c-Jun, c-Fos, and
ERK1/2 are shown in Figure 2b (right panel). These
trends captured by the simulated BN ensembles appear
similar to experimental data from molecular assays per-
formed on in vivo and in vitro replicates (which contain
a large number of cells). While this requires additional
quantitative and mechanistic evaluation, it is important
to note that such continuous protein activity profiles
cannot be generated using traditional BNs. Before
further evaluation with experimental data we analyzed
the reproducibility of our approach with respect to the
network depicted in Figure 1.
Figure 1 Putative Crosstalk Network for Simulation. The network shows signaling interactions due to extracellular ligands including: EGF, IGF-
1, INS, and TNFa. The pathways share common adapter proteins (e.g., SHC and GRB2) as well as downstream signals (ERK1/2 and c-Fos/c-Jun
activation).
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Reproducibility of Protein Activity Profiles
We systematically evaluated the reproducibility of the
asynchronous BN ensembles of the model shown in Fig-
ure 1 by analyzing their response to different treatment
conditions. For each treatment condition, we simulated
100 replicates with 1000 cells per replicate (i.e., 100,000
cells per treatment condition). Each treatment condition
is defined by combinatorial stimulation of the four
extracellular ligand cues: (i) EGF, TNFa, IGF-1, and INS
combined; (ii) TNFa and INS; (iii) TNFa and IGF-1;
(iv) TNFa and EGF; (v) EGF only; (vi) IGF-1 only; (vii)
INS only; (viii) TNFa only; (ix) and no active extracellu-
lar ligands (the control group). We assumed that each
cell is exposed to enough ligand in order to activate a
sufficient number of receptors for signal propagation.
Hence, for each of the simulated treatment conditions
100% of the cells receive stimulation. Moreover, follow-
ing the logic of Boolean abstraction of protein concen-
tration, we assumed that the ligand is switched ‘ON’ in
every cell upon initialization.
Figure 3(A) shows the dynamic responses of the simu-
lated replicates in the treatment group (i), the combined
stimulation of all extracellular ligands. Each of the 12
plots shows the activity profile for one protein from a
random sampling of eight replicates. Even though the
activity profile of each replicate is noisy, the overall
trend across the eight replicates in the (i) treatment
group appears to be reproducible. To analyze this
further, we calculated the coefficient of variation (CV)
for every treatment group (see Methods). These results
are summarized in the heatmap in Figure 4(A). The
rows of the heatmap correspond to the treatment
groups and the columns to proteins in our model. Each
cell shows the normalized CV across all proteins and
treatment where increasing color saturation signifies
decreasing reproducibility. For instance, the simulated
treatment with all ligands produces highly reproducible
changes in steady state protein activities, whereas there
is considerable variation in the absence of any treat-
ment. Overall, the protein activation across replicates is
Figure 2 Overview of Boolean Network Ensembles. (A) A single synthetic cell as a Boolean network (left) along with discrete dynamic
response of proteins in one simulated cell to INS treatment (right). (B) The aggregate activity profiles of four proteins (right) across 1000
simulated cells (a replicate) in response to INS treatment. The abscissa shows time steps and the simulation terminates when all cells have
reached steady state.
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generally reproducible and well within the range of
actual experiments [40].
In Figure 4(B), we show the distribution of the CV for
the steady state protein activities across all treatment
groups as a box and whisker plot. Similarly, Figure 4(C)
shows the reproducibility across the proteins for each
treatment group. Whereas the heatmap of Figure 4(A)
shows information on the CV per protein per treatment
condition, the plots in Figures 4(B) and 4(C) visualize
the overall behavior of the model across each treatment
condition and protein, respectively. We found that treat-
ment conditions (iii), (vi), (viii) and (ix) - IGF-1 and
TNFa, IGF-1 only, TNFa only, and the untreated con-
trol group - were the least reproducible in comparison
to all other treatment conditions. For the control group,
a possible explanation for the reproducibility result is
that the median activity of proteins in the control group
is very low. As a result, signaling molecules other than
ligands and receptors have a very low probability of
being active at initialization, in order to simulate a back-
ground level of hepatocyte proliferation. This very low
mean value has the effect of inflating the CV. In the
case of IGF-1 or TNFa, the low reproducibility could be
due to the inclusion of fewer reactions than the two
other growth factors (EGF and INS). Hence, stimulating
with IGF-1 or TNFa may not sufficiently stimulate the
individual BNs for the entire ensemble to synchronize in
response to treatment. Similar logic governs the model
reproducibility following combined stimulation with
IGF-1 and TNFa. These results also help to illuminate
the sensitivity of our simulation approach to the topol-
ogy of the signaling network. Importantly, the key end-
point of the model, AP-1 formation, is very reproducible
across all treatment conditions.
Comparison with Experimental Data
We used experimental data on primary hepatocytes in
culture [41] for a preliminary evaluation of our simula-
tion approach and putative crosstalk model. In this
experiment, rat primary hepatocytes were treated with
varying concentrations of EGF and/or TNFa, and then
the proportion of cells entering S phase (DNA Synthesis)
was measured using Bromodeoxyuridine (5’-bromo-2’-
deoxyuridine, BrdU). Although we do not explicitly
model S phase in our network, the formation of the AP-1
transcription factor complex is believed to precede S
phase in cell cycle progression. Hence, we assumed the
formation of AP-1 to be a potential surrogate of S phase
and, therefore, correlated with BrdU incorporation. We
adjusted the probabilities of activation for proteins in our
network in order to closely approximate the levels of
BrdU incorporation in the absence of any treatment
(control group). Further details on the calibration of the
model are described in the Methods section.
We simulated the effects of different treatments on
AP-1 formation.
Figure 5 shows the results of simulating 10 replicates for
each of the treatment conditions including: combined
EGF and TNFa, EGF only and TNFa only. The graphs in
Figure 5 show the predicted activity profile of the AP-1
transcription factor complex across simulation time steps
with the probability of activation for the treatment mole-
cules set to 100%. Next, we simulated the concentration
dependent effects of EGF stimulation. The steady state
levels of AP-1 activity are shown in Figure 6 with the
experimental data on BrdU incorporation for different
treatment conditions. For each treatment condition, we
simulated 100 replicates with 1000 cells per replicate. The
plot in Figure 6 has a solid black line representing the
mean of the fold change of AP-1 activity relative to mean
of the control activity (at steady state) across all replicates.
Based on the replicate data, we also report the 95% confi-
dence interval for each plot – the shaded blue region. The
experimental data from [41] on BrdU incorporation is
shown as points with the standard deviation. The simula-
tion is able to reproduce the experimentally observed
trends in DNA synthesis. As EGF is known to activate the
AP-1 transcription factor complex (as a c-Jun/c-Fos
dimer) in hepatocytes and other cell types [42], this result
Figure 3 Simulated Replicate Protein Activity Profiles. The
protein activity profiles after treatment with all ligands for 1000
simulated cells. The graphs show the time course response of a
subset of proteins in the model including: (A) receptor tyrosine
kinases, (B) select intermediate signaling proteins, and (C) select
transcription factor proteins including c-Fos and c-Jun. For instance,
EGFR shows an initial increase in activity followed by inactivation
due to feedback inhibition, which is consistent with our knowledge
of receptor internalization and ubiquitination. We have not included
similar feedback for the other receptor in the current model.
Similarly, IRS is a hub signaling protein with a number of potential
inhibitors and some of these are represented in our model. The
activation of the MAPKs (ERK1/2) and transcription factors (AKT, c-
Fos, c-Jun) in our simulation highlights the putative signaling
cascade responsible for activating immediate early genes, which is a
key step in cell cycle progression into S phase.
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is consistent with the literature. Finally, the model did not
predict the synergistic effect of EGF and TNFa stimulation
on S phase. We believe this suggests mechanistic limita-
tions in our crosstalk model that could be improved by
incorporating additional mechanistic information about
the downstream interactions between TNFa and EGF
pathways.
Discussion
BNs have been used extensively to model the dynamics
of molecular signaling and genetic regulatory networks.
Because they require the discretization of molecular
activity levels, however, a BN cannot be readily used to
model the continuous concentration- and time-depen-
dent effects of treatments. To address this issue we
extended traditional BNs in three ways. First, we model
the molecular response of an individual cell using a BN.
Hence, we assumed that the average activity of signaling
molecules in individual cells exhibits a switch-like (ON
or OFF) response. Although this may not always be the
case, we believe it is more biologically plausible than a
binary representation of tissue level molecular activities.
Figure 4 Reproducibility of Protein Activities Across Simulated Replicates. (A) The heatmap shows the coefficient of variation for protein
activity (columns) following different treatments (rows). The color intensity increases with decreasing reproducibility. The nine treatments shown
in the rows are (i) EGF, TNFa, IGF-1, and INS combined; (ii) TNFa and INS; (iii) TNFa and IGF-1; (iv) TNFa and EGF; (v) EGF only; (vi) IGF-1 only;
(vii) INS only; (viii) TNFa only; (ix) and no active extracellular ligands (Control). Each cell in the heatmap represents the coefficient of variation for
the activity of one protein across 100 replicates with 1000 cells/replicate (a total of 100,000 Boolean network simulations). (B) The distribution of
CV across each treatment condition. (C) The distribution of CV across each protein.
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Second, we assumed that cellular response to stimula-
tion is nondeterministic. It has been suggested synchro-
nous updating schemes for simulating BNs can produce
spurious attractors that disappear in the presence of
noise [43,44]. An asynchronous updating scheme, on the
other hand, allows for variability (or noise) in cellular
responses: two identical cells with the same initial con-
figurations respond differentially to the same stimulus
over time. Although asynchronous updating is not new
in BNs [44], we define a probability of activation for
each molecular species that is amenable to calibration
and evaluation using experimental data. Third, we simu-
late an ensemble of asynchronous BNs to estimate the
aggregate activity of each molecular species across cell
populations. Our results show that this approach pro-
duces continuous responses similar to experimental
observations from tissues. We believe this opens up new
possibilities for estimating quantitative dose- and time-
dependent responses in toxicology and in disease pro-
gression using knowledge of molecular mechanisms.
For this work, we used this simulation methodology to
analyze the dynamics of a specific biochemical interac-
tion network, which was constructed to investigate early
molecular events surrounding hepatocellular prolifera-
tion. This is important because sustained cell prolifera-
tion is one of the key events in the progression of liver
cancer. We find that (a) our extension of BNs yields
highly reproducible results that have variability conso-
nant with biological data and (b) our pathway-driven
preliminary cytokine and growth factor protein signaling
network is concordant with experimental observations
on DNA synthesis in hepatocytes.
We investigated the effects of protein deletion from
the network. In Additional file 1, we show a heatmap of
these results. From this analysis, we believe our network
is robust to the deletion of single proteins. Additionally,
this information helps illustrate important signaling
nodes in the network. For example, ERK1/2 and JNK
appear to play important roles, since the removal of
these changes the steady state values of other signaling
molecules. To our surprise, the removal of IRS activity
did not have a large effect on the signaling processes
relative to other experimental conditions, even though
the signaling molecule has a high connectivity in the
graph.
A number of formalisms have been used to model the
dynamics of eukaryotic cell cycle initiation/progression.
Tyson and coauthors used ordinary differential equa-
tions (ODEs) to describe key cell division in frog oocytes
[45]. Zielinski and colleagues used fuzzy Boolean logic
to simulate receptor mediated crosstalk preceding cell
proliferation in SKOV3 human epithelial cell line [46].
Similar fuzzy models have been proposed by others [47].
One advantage common to both techniques - i.e., ODEs
and fuzzy logic - is that they can represent continuous
or multivalued treatment concentrations. While these
methods are powerful, they predict the population beha-
vior of molecular species without emphasizing individual
cellular protein activity. Our objective is to model the
Figure 5 AP-1 Activity Response Profiles Across Simulated
Replicates to Different Treatment Conditions. Each replicate line
represents the activity of AP-1 across 1000 simulated cells. There are
three different treatment conditions: (A) EGF only, (B) TNFa only or
(C) EGF and TNFa.
Figure 6 Quantitative Comparison Between Simulation and
Experimental Results. The quantitative comparison of simulated
concentration response data with experimental data on EGF. The
solid line represents the mean steady state fold change of AP-1
activity (relative to control) across 100 replicates with 1000 cells per
replicate, simulated over a range of values from 0 to 25 ng/ml EGF.
The 95% confidence interval across replicates is in blue. The
experimental results of BrdU incorporation are plotted with standard
deviation as points.
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heterogeneous response of cell populations in order to
estimate histological effects due to different treatments,
which necessitates a modeling paradigm with individual
cell clarity.
In order to help unravel the mechanisms of toxicity,
we are compelled to investigate a simulation framework
with a strong emphasis on network topology and
reduced parameter space. ODE-based methods involve
rate constants which are often difficult to quantify. Test-
ing perturbations to systems of ODEs is not always
straightforward with limited data. With BN dynamics,
we lose some resolution of time but significantly reduce
the number of parameters. We believe our technique is
amenable to high throughput modeling of perturbations
over a diverse chemical landscape, where the calibration
of parameters can be limited due to scarce data on large
numbers of environmental chemicals. We hope the
modeling framework proposed will be useful in testing
chemical perturbations from HTS data to generalized
networks on signaling events assessed at the tissue level.
A comparable modeling framework was proposed [18]
which also considered populations of networks. There
are several differences in the modeling approaches. First,
we use a binary representation of protein activity in a
single cell while [18] used a ternary description to cap-
ture the level of protein expression relative to a popula-
tion average under normal conditions. An ON/OFF
representation of protein activity may not always be suf-
ficient (e.g., caspase 8 activity) but it is generally consis-
tent with single cell level observations (e.g. flow
cytometry or high-content screening). The ternary
representation used by [18] is based on western blot
data on individual proteins with a comparison between
treatment and control groups. While a mathematical
transformation could relate one approach to another,
the two techniques use a different abstraction for
describing single cell biology.
Second, there is a subtle distinction between the
abstraction of population level behavior between the
two approaches. The authors of [18] calculated the aver-
age behavior of proteins across a set of BN whereas we
use summation. This allows us to compare dose-depen-
dent differences in potency and efficacy between treat-
ments. Furthermore, it also enables the quantitative
evaluation of population level “up-regulation” or “down-
regulation” between treatment and control groups with-
out using a ternary representation.
Third, the authors of [18] evaluate the effects of
knockouts by maintaining some of the proteins in at
‘control’ or ‘below control’. On the other hand, we con-
sider the effects of dose-dependent perturbations in pro-
tein activities (e.g. extracellular ligands or intracellular
signaling molecules) by using Hill functions to define
probability of activation for certain protein(s) across the
cell population. To our knowledge, no one has used this
approach to incorporate concentration-response data in
a BN modeling framework. The ability to reproduce and
predict concentration-response data is essential for toxi-
cological applications, bridging data from toxicity studies
with systems biology to anticipate adverse outcomes.
We did not consider edge weights as an adjustable
parameter for the model. All edges are weighted equally
(set to 1.0). Modifying the edge weights would change
the dynamics of the simulation. For example, in [48],
the authors use a sigmoid function of the weighted sum
to determine the probability per node in the propagation
of the signal. Their technique offers a unique method
for additional stochasticity to a threshold modeling fra-
mework. Modifying edge weights would require careful
consideration of the updating scheme (describe in Meth-
ods), which would be affected if the edge weights were
allowed to vary throughout simulation.
The thresholds described in the methods section pro-
vide a tunable parameter for investigating the signaling
interactions. Each protein has a threshold value which
defines the biochemical interaction surrounding its
activity - that is, the logic underlying the interaction of
the activating and inhibiting molecules. To illustrate the
effects of modifying the threshold of a molecule in a
network, we provide Figure 7: a truth table for variations
on threshold values. The truth table displays the differ-
ences in the activity of a molecule, P, after one update
(time step), as a function of the input value - the sum of
the states of the inhibiting proteins subtracted from the
sum of the states of the activating proteins - and the
threshold value. Setting the threshold to an integer
value allows for the molecule to maintain its current
state whereas, following the discussion of edge weights,
setting the threshold to a noninteger value will force a
decisions for a (new) value of 0 or 1.
For the crosstalk network model investigated in this
paper, randomly increasing the threshold of a single
molecule from an integer to a noninteger value has little
effect on the steady state levels of AP-1 (results not
shown). These changes can effect the activity profile of
the proteins over time - allowing sustained (threshold =
0.0) or transient activity (0.0 < threshold < 1.0) after acti-
vation, or recapitulating protein lability and potential loss
of signal. For example,in the case of EGF stimulation, the
receptor has negative feedback encoded in the model.
Therefore, increasing the thresholds of proteins down-
stream of EGFR to noninteger values affects the overall
activity profiles of the molecules across time (results not
shown). Increasing thresholds by integer values can have
the same effect as node deletion when the number of
activating (input) molecules is equal to the threshold. In
general, increasing the threshold increases the required
input value for signal propagation.
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There are some important limitations in our approach.
First, the model presented in this work did not consider
any communication between the cells (autocrine or
paracrine signals), or between the cells and the extracel-
lular matrix. Contact inhibition and matrix attachment,
and cell communication are important factors in cell
cycle progression and we are considering their role in a
cell-based model of liver tissues [7]. Second, we also
recognize that the biochemical interaction network we
used in this work is incomplete. Our primary goal was
to develop a flexible modeling approach that can incre-
mentally accommodate additional mechanistic informa-
tion as it becomes available.
The BN used in this work was constructed semi-auto-
matically from a molecular network topology, which was
defined with little manual intervention using curated
information on pathways. In future work we will evaluate
the effects of additional pathways in the crosstalk net-
work, for example, the interleukin protein family as well
as the behavior of mito-inhibitors like Transforming
Growth Factor Beta (TGF-b). For this work, we did not
investigate alternative hypotheses on the signaling
mechanisms of individual hepatocytes. The model devel-
opment in [16] provides a method for investigating sig-
naling differences between cell types. Understanding the
signaling differences between cell types, such as, kinetic
differences, is undoubtedly important in extrapolating
cell line in vitro data to acute/chronic in vivo responses.
Leveraging information from alternate pathway databases
[49-51] should increase the descriptive power of our
model, and is critical to decipher the role of molecular
crosstalk in cellular responses to endogenous ligands and
xenobiotics.
AP-1 is among several transcription factors important
for cell cycle initiation/progression. In the current
model we did not include gene expression regulated by
the activation of transcription factors. Therefore, we
chose AP-1 formation as the surrogate for downstream
events, since it promotes cell cycle progression through
increased expression of proteins, such as cyclin D1 [52],
and antagonizes the function other molecules, such as
p53 and p21 [53]. As we continue to develop this
model, we can incorporate the activity of additional
important transcription factors, such as Nuclear Factor
kappa B (NF-B) and Forkhead Box (FOX) proteins.
Finally, most BN based approaches cannot directly relate
simulation time steps to physiologic time intervals. This
is an open problem in BN simulation and our approach
is not immune to this issue, but we hope to address this
in future work.
An advantage of asynchronous BN ensembles is that
they can be simulated very rapidly. A single simulated
treatment group (1000 cells/replicate) can be executed
on a computer in minutes, while some of the more
complex simulations, such as the reproducibility investi-
gation (Figure 4) can be simulated on the scale of hours.
However, since each cell is initialized/simulated to
steady state individually, the approach is amenable to
parallelization. We believe this efficiency will allow us to
simultaneously investigate the role of molecular network
topology using background knowledge on quantitative
tissue level responses from experimental data.
Conclusions
Systems biology approaches are vital for efficiently analyz-
ing the effects of environmental contaminants on living
tissues in order to evaluate the potential risk to public
health. We developed asynchronous threshold Boolean
network ensembles for translating mechanisms to in vitro
and in vivo observations on molecular activity. The repro-
ducibility of our modeling framework was evaluated by
systematically analyzing the variability of our predictions
across multiple simulations. We also showed that popula-
tions of hepatocytes can be simulated in this manner to
predict experimentally observed quantitative responses.
We believe that ensembles of Boolean networks can allow
us to probe deeper mechanistic questions about the mode
of action for chronic liver injury. We are testing this mod-
eling approach as part of a broader computational and
experimental effort aimed at estimating the putative effects
of xenobiotics on the human liver by integrating chemical
concentration, molecular pathways, cellular responses, and
the role of cell-cell communication.
Figure 7 Truth Table for Update Scheme. The truth table
illustrates how we calculate the activity of a protein (P) after one
time step δτ+1P based on the aggregate input (column 1) and
differential threshold values (columns 2 - 7). For example, row 2
shows that the activity of P remains the same as the previous time
step (δτ+1P = δ
τ
P) when the aggregate input is 0 and θP = 0, and
δτP = 0 for all other threshold values. Similarly, the other row show
of the consequence of varying the threshold for other values for
the aggregate input. Note the distinction between integer and non-
integer choices for the threshold.
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Methods
Threshold Boolean Network
We begin the definition of the cellular model with a
biochemical interaction network as a signed, directed
graph, G(V,E), where V is the set of all vertices (or pro-
teins/molecules) and E is the set of all edges (or reac-
tions). Let v Î V. Then, we define the set of all
predecessors of v:
Pv = {u ∈ V|euv ∈ E} (1)
For each edge euv Î E we have Sign(euv) Î {+,-} where
‘+’ indicates u is involved in the activation of v and ‘-’
indicates u is involved in the inhibition of v. Now we
define Av ⊆ Pv as the set of all activators of v. More for-
mally,
Av = {u ∈ V|euv ∈ Pv ∧ Sign(euv) = +} (2)
Likewise, we define Iv ⊆ Pv as the set of all inhibitors
of v,
Iv = {u ∈ V|euv ∈ Pv ∧ Sign(euv) = −} (3)
Furthermore, we let A =
⋃
v∈V
Av and I =
⋃
v∈V
Iv, and let n
be the number of proteins in the graph. Additionally, we
store the binary vector, τ = (δτv1 , δ
τ
v2 , ..., δ
τ
vn), of the state
(active or inactive) of every vertex at time τ. The state of
a protein is dependent on the states of its predecessors.
Therefore, we define a vector,  = (θv1 , θv2 , ..., θvn), repre-
senting the threshold of activation for each vertex, a bio-
logically inspired variable guiding the interplay
predecessor vertices and protein activation. For the
model, all thresholds were set to 0.0 with the exception
of AP-1 formation, which is set to θAP-1 Î (1,2). This
modification to the AP-1 threshold reflects the underly-
ing biochemistry in that both c-Jun and c-Fos must be
active for the activation of the AP-1.
Finally, we define the vector  = {φv1 ,φv2 , ...,φvn},
which represents the probability of activation for each
protein. For most models/proteins, there is a basal level
of activity. We assume that individual BNs can have dif-
ferent protein activity profiles upon initialization (τ = 0),
which allows for biological variability across the cell
population.
Now, for any direct, signed graph, we formally define
our model as follows:
Cτ = (V,A, I,τ ,,) (4)
Temporal Evolution of the Boolean Network
All other components of the model, Cτ, are fixed during
the simulation except for one, Δτ, which is the state
vector for v Î V at a given time step. This value is


























The steady state protein activity in a BN is expressed
as the following state vector:
τ = (δτv1 , δ
τ




In this model, the probabilities of activation for proteins,
F, are considered a tunable parameter. The probabilities
determine the state of each BN at τ = 0, which influ-
ences the dynamics of protein activation across the
ensemble. We adjusted the values of F in three steps
using experimental data where available. First, we
assumed that in the absence of any treatment (i.e.,
experimental controls) the ligands, receptors, the adap-
tor proteins (GRB2 and SHC), the insulin receptor sub-
strates (IRS and IRS-2), and non-ligand receptors
(ErbB2 and ErbB3) have  = 0.0. Second, the values of
Ffor the remaining proteins in the network were
increased until the predicted activity of AP-1 was close
to the experimental level of BrdU incorporation in the
control group (~1.5% DNA Synthesis [41]). For these
proteins, the probability of activation  = 0.0025 gave
1.49% ± 0.05 of AP-1 formation. Third, we assumed
that the probability of activation of ligands in the model
was related to the experimental concentration of the
ligand. For EGF, we used the Hill function (Equation 8)
to describe the relationship between probability of acti-







We used the BrdU concentration response data [41]
to estimate the parameters for Equation 8. In order to
use the Nelder-Mead algorithm to make a maximum
likelihood estimation of Vmax, KA and n, we assumed
that EGF activity corresponds to AP-1 activation.
Although the network was encoded with negative feed-
back for the EGF receptor, representing the internaliza-
tion and ubiquitination of this receptor, we make this
assumption based on the simulation results with EGF =
1.0 (Figure 5a). The maximum likelihood estimates we
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found are n = 0.7, KA = 5.9ng/ml and Vmax = .28 (prob-
ability of activation).
Simulating Populations of Cells
The ensemble of asynchronous threshold Boolean net-
works at a time step is represented as:
Cτ = {Cτ1, ...,Cτm}
The aggregate activity of each protein across the
ensemble at one time step, denoted as vτ, is calculated





Similarly the steady state activity of a protein across
the ensemble is denoted as vT.
Hence, the coefficient of variation of the steady state





Implementation and Input Formats
The simulator is implemented in Python and the net-
work model was produced interactively using Cytoscape.
The molecular interaction network topology is defined
in the Cytoscape exported format and protein informa-
tion as well as quantitative parameters can be defined in
the node attributes file (e.g., protein name, probabilities
of activation, and threshold). The Python code as well
as the network model are included (see Additional file 2
and Additional file 3).
Additional material
Additional file 1: Evaluation of Network Behavior for Protein
Knockouts. The heatmap shows the simulation results for deleting
individual proteins from the network. Each cell in the heatmap
represents the mean protein activity at steady state relative to control
across 20 replicates with 100 cells per replicate. The color intensity
indicates the protein (x-axis) behavior at steady state relative to the
baseline simulation (no protein knockout). The y-axis indicates the
protein deletion.
Additional file 2: network_model.zip. The Cytoscape export files for
the crosstalk network model on AP-1 formation. These files are to be
used in conjunction with the python_simulation_code.
Additional file 3: python_simulation_code.zip. The source code to
load the network model and produce the simulation results reported in
the paper. Refer to the README file for instruction.
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